US 10501551
Multivalent and multispecific 41BB-binding fusion proteins
granted A61PA61P29/00A61P35/00
Quick answer
US patent 10501551 (Multivalent and multispecific 41BB-binding fusion proteins) held by Inhibrx, Inc. expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 64
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/04, A61P43/00